| Literature DB >> 23509464 |
Pietro Canzi1, Anna Berardi, Carmine Tinelli, Filippo Montevecchi, Fabio Pagella, Claudio Vicini, Marco Benazzo.
Abstract
Aims. To evaluate thirteen years of hyoid suspension experience in multilevel OSAHS surgery, for which hyoidthyroidpexia represented the exclusive hypopharyngeal approach applied. Materials and Methods. From 1998 to 2011, a bicentric retrospective study was conducted: all adult patients with a diagnosis of OSAHS were enrolled. Specific eligible criteria were established. Pre-/postoperative data concerning ENT and sleep findings were recorded. Recruited subjects were surveilled for a follow-up range from 6 to 18 months. Results. A total of 590 hyoid suspensions were evaluated, but only 140 patients met the specific inclusion criteria. A success rate of 67% was obtained. No intraoperative adverse events or major complications occurred. Excessive daytime sleepiness was observed in 28% of nonresponders. Despite the homogeneous candidate anatomy, ENT awake findings changed differently after surgery. Statistical analysis revealed multilevel surgery to be more effective when AHI < 30. Postoperative AHI was statistically not influenced by preoperative BMI. Conclusions. Hyoid suspension in multilevel treatment is effective when short-term results are considered. The necessity of a more valuable anatomic-based diagnostic approach is crucial to guide the patient selection. Long-term followups and randomized prospective trials with case-control series are needed to increase the level of evidence of this surgery.Entities:
Year: 2013 PMID: 23509464 PMCID: PMC3590780 DOI: 10.1155/2013/263043
Source DB: PubMed Journal: Int J Otolaryngol ISSN: 1687-9201
Pre-/postoperative statistical data.
| Median | Lower quartile | Upper quartile | Gain | ||||
|---|---|---|---|---|---|---|---|
| Preoperative | Postoperative | Preoperative | Postoperative | Preoperative | Postoperative | ||
| AHI (ev/h) | 31 | 12 | 21 | 6 | 44 | 25 | −19 ( |
| ESS | 10 | 8 | 8 | 6 | 12 | 9 | −2 ( |
| NOH | N3O4cH3t | N0O1cH1t | N2O3cH2t | N0O0H0 | N3O4cH3t | N0O1cH1t | −N3O3cH2t ( |
| BMI (Kg/m2) | 27.8 | 27.5 | 26.5 | 26.0 | 29.4 | 29.0 | 0 ( |
| Followup (mo) | 9 mo | 7 mo | 14 mo | / | |||
Gain: median postoperative value − median preoperative value. mo: months.
Multilevel treatment response rates.
| Responders | Nonresponders | ||||
|---|---|---|---|---|---|
| Recovered | Cardiovascular prevention | Improved | Unchanged | Worsened | |
| Percentage | 44% | 23% | 18% | 7% | 8% |
|
| |||||
| Total | 67% | 33% | |||
Figure 1Comparison of pre-/postoperative AHI reduction between responder and nonresponder groups.
Figure 2Comparison between postoperative ESS and postoperative AHI.
Figure 3Comparison between postoperative NOH and postoperative AHI.
Figure 4Statistical correlation between preoperative BMI and postoperative AHI.